What % of sales was from the expensive Pfizer products... how much of that business will be taken up by generic product lines... could be a bad move on pfizers behalf i feel...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025